2026 NPPES data Optometrist NPI 1205816337 O.D.
Verify on CMS →

STEPHEN CYFORD, O.D.

Optometrist in BEL AIR, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
509
Medicare Part D claims · 198 beneficiaries · Optometrist avg: 257
Generic prescribing
69%
generic claims · 31% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$61.94
3 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: STEPHEN CYFORD, O.D. is a Optometrist ([object Object]) practicing in BEL AIR, Maryland with a Medicare Part D prescribing footprint of 509 claims across 198 beneficiaries — 31% brand-name prescribing . Their CMS MIPS Final Score of 75/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $61.94 across 3 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: STEPHEN CYFORD, O.D. reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 509 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

STEPHEN CYFORD, O.D. at a glance

Below national average

NPI registry status

Active

Issued 01/17/2006

NPI 1205816337

Primary specialty

Optometrist

High-volume

60,463 US NPIs in this specialty

Medicare Part D claims

509 98% vs specialty avg

2023 prescription claims

Specialty avg: 257

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Maryland

How Optometrist compares to other specialties among Maryland providers

Maryland providers

Optometrist share within Maryland

1. Optometrist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Optometrist share within Maryland

Medicare quality performance — MIPS

STEPHEN CYFORD, O.D.'s 2023 MIPS final score plotted against the Optometrist national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Optometrist) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Optometrist) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

STEPHEN CYFORD, O.D. is a Optometrist provider practicing in BEL AIR, Maryland, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: O.D.. NPI: 1205816337. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

STEPHEN CYFORD, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 620 BOULTON ST, BEL AIR, MD, 21014, with a listed phone of (410) 836-7010. NPI 1205816337 was issued on 01/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CYFORD most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 509 prescription claims written by this provider, covering 198 Medicare beneficiaries and totaling roughly $150K in drug spend, split 31% brand-name and 69% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

620 BOULTON ST
BEL AIR, MD 21014

Provider Details

NPI 1205816337
Specialty Optometrist
Credentials O.D.
Gender Male
NPI Issued 01/17/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Hospital and facility affiliations

Facilities where STEPHEN CYFORD, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

JOHNS HOPKINS UNIVERSITY
LUTHERVILLE, MD

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for STEPHEN CYFORD, O.D.. Source: openpaymentsdata.cms.gov.

Total received

$62

Largest payer

Harrow Eye, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

STEPHEN CYFORD, O.D. — brand share 31.0%
Specialty average (est.)

31% brand-name claims vs 69% generic, on 509 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

509
Total Claims
$150K
Total Drug Cost
198
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,134
Total Day Supply
32,641
Brand vs Generic
31% brand / 69% generic
Brand Drug Cost
$133K
Generic Drug Cost
$16K

Patient Demographics

Average Patient Age
77.7 years
Avg HCC Risk Score
1.09
Gender Split
68% female / 32% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
221
Restasis
Cyclosporine
52
Erythromycin
Erythromycin Base
37
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
33
Brimonidine Tartrate
30
Timolol Maleate
29
Cyclosporine
23
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
19
Lumigan
Bimatoprost
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Optometrist Overview

How STEPHEN CYFORD, O.D. fits within the Optometrist landscape nationally.

60,463
Optometrist Providers in US
56
States with Optometrist
257
Avg Claims per Provider

STEPHEN CYFORD, O.D.'s 509 claims are above the specialty average of 257.

Nearby Optometrist Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as CYFORD.

Compare Optometrist nationally: see state-by-state distribution →

Frequently Asked Questions

What is STEPHEN CYFORD, O.D.'s specialty?
STEPHEN CYFORD, O.D. specializes in Optometrist and practices in BEL AIR, Maryland. Credentials: O.D..
How much does STEPHEN CYFORD, O.D. prescribe under Medicare Part D?
In 2023, STEPHEN CYFORD, O.D. wrote 509 Medicare Part D claims totaling $150K in drug costs for 198 beneficiaries.
What is STEPHEN CYFORD, O.D.'s Medicare quality score?
STEPHEN CYFORD, O.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is STEPHEN CYFORD, O.D. located?
STEPHEN CYFORD, O.D. is located at 620 BOULTON ST, BEL AIR, MD, 21014. Phone: (410) 836-7010.
What is STEPHEN CYFORD, O.D.'s NPI number?
STEPHEN CYFORD, O.D.'s National Provider Identifier (NPI) is 1205816337, issued on 01/17/2006.
Does STEPHEN CYFORD, O.D. prescribe more brand-name or generic drugs?
STEPHEN CYFORD, O.D.'s prescribing is 31% brand-name and 69% generic drugs by claim count, with $133K in brand drug costs.
How many Optometrist providers are there in the US?
There are 60,463 Optometrist providers across 56 states in the US. The average Optometrist provider writes 257 Medicare Part D claims per year.
What drugs does STEPHEN CYFORD, O.D. prescribe most often?
Based on 2023 Medicare Part D data, STEPHEN CYFORD, O.D.'s most frequently prescribed drugs include Latanoprost, Restasis, Erythromycin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does STEPHEN CYFORD, O.D. accept Medicare?
STEPHEN CYFORD, O.D. appears in CMS Medicare data with 509 Part D claims and 198 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify STEPHEN CYFORD, O.D.'s credentials?
STEPHEN CYFORD, O.D.'s NPI is 1205816337 with credentials O.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology